Literature DB >> 2110073

Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea.

J H Check1, K Nowroozi, J S Chase, A Nazari, D Shapse, M Vaze.   

Abstract

The efficacy of a technique of gonadotropin suppression and human menopausal gonadotropins (hMG) to induce ovulation in women with hypergonadotropic amenorrhea was evaluated in 100 consecutive women. Ovulation was achieved in 19% of cycles (68/361), the pregnancy rate per cycle was 5.2% (19/361), and the viable pregnancy rate was 2.2% (8/361). In the majority of the successful cases, estrogen was used to decrease the elevated luteinizing hormone and follicle-stimulating hormone levels, especially where the ethinyl estradiol therapy alone induced a rise in endogenous 17 beta-estradiol levels with hMG used to boost the follicle to maturation. Although the success rate is low, this technique can result in some successes in otherwise almost hopeless cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110073     DOI: 10.1016/s0015-0282(16)53514-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

Review 1.  Mild ovarian stimulation.

Authors:  Jerome H Check
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

2.  Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.

Authors:  Sara Pinelli; Paolo Giovanni Artini; Stefano Basile; Maria Elena Rosa Obino; Claudia Sergiampietri; Diana Giannarelli; Giovanna Simi; Vito Cela
Journal:  J Assist Reprod Genet       Date:  2017-12-05       Impact factor: 3.412

3.  "Poor responders": screening and treatment possibilities.

Authors:  F Olivennes; R Fanchin; D De Ziegler; R Frydman
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

4.  Spontaneous ovulation in functionally agonadal women prior to oocyte donation: incidence and remedies for avoiding cancellation.

Authors:  M V Sauer
Journal:  J Assist Reprod Genet       Date:  1993-07       Impact factor: 3.412

5.  Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?

Authors:  E al-Mizyen; L Sabatini; A M Lower; C M Wilson; T al-Shawaf; J G Grudzinskas
Journal:  J Assist Reprod Genet       Date:  2000-03       Impact factor: 3.412

Review 6.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Authors:  Shannon D Sullivan; Philip M Sarrel; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-12       Impact factor: 7.329

7.  Failed ovarian cortex transplant but successful ovulation induction in a cancer survivor with premature ovarian failure: A paradox.

Authors:  Nikita Naredi; Pankaj Talwar; Sandeep Karunakaran
Journal:  Med J Armed Forces India       Date:  2020-07-11

8.  Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.

Authors:  Yukiyo Kasahara; Satoko Osuka; Natsuki Nakanishi; Tomohiko Murase; Tomoko Nakamura; Maki Goto; Tomomi Kotani; Akira Iwase; Fumitaka Kikkawa
Journal:  Reprod Sci       Date:  2020-07-31       Impact factor: 3.060

9.  A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency.

Authors:  Ziad R Hubayter; Vaishali Popat; Vien H Vanderhoof; Obioma Ndubizu; Diane Johnson; Edie Mao; Karim A Calis; James F Troendle; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

Review 10.  Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI).

Authors:  Bunpei Ishizuka
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.